CD8A and Miyoshi myopathy: Treatment of newly diagnosed MM patient BMMC with anti-GAL-3, but not with anti-HLA-DP/DQ/DR, induced proliferation of T cells, including CD8+ Tc cells (45%: Patient #1, 38%: Patient #2) and CD4+ Th cells (13%: Patient #1, 9%: Patient #2) (Fig. 7B).